Related Experiment Video
Updated: Jun 4, 2025
04:15
Author Spotlight: Development of a Method for Identifying Small Molecular Antagonists of β2 Integrin Activation
Published on: February 2, 2024
1.7K
Cilengitide sensitivity is predicted by overall integrin expression in breast cancer
Nomeda Girnius1,2, Aylin Z Henstridge3, Benjamin Marks4
1Department of Cell Biology, Harvard Medical School, Boston, MA, 02115, USA. Nomeda_Girnius@hms.harvard.edu.
Breast Cancer Research : BCR
|December 20, 2024
Summary
Integrin inhibitors like cilengitide show promise for triple-negative breast cancer (TNBC). Low integrin levels predict sensitivity, while high levels and fibronectin confer resistance, guiding future treatment strategies.
Area of Science:
- Oncology
- Molecular Biology
- Drug Discovery
Background:
- Triple-negative breast cancer (TNBC) has limited treatment options and a poor prognosis.
- Identifying targeted therapies is crucial for improving patient outcomes.
- Integrin inhibitors are being investigated, but their efficacy and predictive markers require further understanding.
Purpose of the Study:
- To identify drugs targeting TNBC vulnerabilities and understand underlying biological responses.
- To investigate mechanisms of cilengitide resistance and identify response biomarkers.
- To assess the generalizability of findings to other integrin inhibitors.
Main Methods:
- Systematic in vitro assays and computational approaches were used to explore cilengitide sensitivity and resistance.
- A pan-integrin inhibitor (GLPG0187) was tested to evaluate generalizability.
- Knockdown experiments and extracellular matrix (ECM) manipulation assessed integrin and ECM roles.
Main Results:
- Cell-derived ECM modulates cilengitide sensitivity; fibronectin addition conferred resistance.
- Elevated overall integrin protein levels, not specific integrins, correlated with cilengitide resistance.
- Luminal breast cancer cell lines with low integrin levels were sensitive to cilengitide, and GLPG0187 showed similar sensitivity profiles.
Conclusions:
- Cilengitide induces death in breast cancer cells with low integrin abundance, with ECM promoting survival.
- Integrin inhibitors are well-tolerated but have mixed efficacy, potentially due to lack of predictive markers.
- Further study of integrin inhibition in breast cancer is warranted, with low integrin levels as a potential predictive marker.
Keywords:
Breast cancerDrug screeningExtracellular matrixIntegrinsProteomicsTriple negative breast cancerMore Related Videos
Related Concept Videos
01:15Activation of Integrins
3.3K
Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
3.3K
01:17Intracellular Signaling Affects Focal Adhesions
2.6K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.6K
01:10Integrins
3.8K
Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
3.8K
01:25Selectins
3.2K
Cell adhesion is an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
3.2K